VERTEX PHARMACEUTICALS INC / MA Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 88.39 | 3,792 | 335,175 | 127,455 | 131.2 K to 127.5 K (-2.89 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 87.68 | 6,403 | 561,415 | 106,011 | 112.4 K to 106 K (-5.70 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 88.39 | 100 | 8,839 | 306,645 | 306.7 K to 306.6 K (-0.03 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 87.68 | 23,804 | 2,087,135 | 306,745 | 330.5 K to 306.7 K (-7.20 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 87.68 | 7,684 | 673,733 | 99,335 | 107 K to 99.3 K (-7.18 %) |
| Feb 15 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 87.66 | 3,842 | 336,790 | 130,080 | 133.9 K to 130.1 K (-2.87 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | A | 86.52 | 12,944 | 1,119,915 | 12,944 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Grant | A | 0.00 | 6,321 | 0 | 20,071 | 13.8 K to 20.1 K (+45.97 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | A | 86.52 | 37,278 | 3,225,293 | 37,278 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Grant | A | 0.00 | 18,204 | 0 | 28,554 | 10.4 K to 28.6 K (+175.88 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | A | 86.52 | 37,278 | 3,225,293 | 37,278 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Grant | A | 0.00 | 18,204 | 0 | 112,414 | 94.2 K to 112.4 K (+19.32 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Grant | A | 0.01 | 4,794 | 48 | 94,210 | 89.4 K to 94.2 K (+5.36 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | A | 86.52 | 24,852 | 2,150,195 | 24,852 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Grant | A | 0.00 | 12,136 | 0 | 131,247 | 119.1 K to 131.2 K (+10.19 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Grant | A | 0.01 | 5,753 | 58 | 119,111 | 113.4 K to 119.1 K (+5.08 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 86.52 | 24,852 | 2,150,195 | 24,852 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.00 | 12,136 | 0 | 127,633 | 115.5 K to 127.6 K (+10.51 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 4,794 | 48 | 115,497 | 110.7 K to 115.5 K (+4.33 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | A | 86.52 | 31,065 | 2,687,744 | 31,065 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Grant | A | 0.00 | 15,170 | 0 | 107,019 | 91.8 K to 107 K (+16.52 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Grant | A | 0.01 | 5,753 | 58 | 91,849 | 86.1 K to 91.8 K (+6.68 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 86.52 | 103,550 | 8,959,146 | 103,550 | |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.00 | 50,567 | 0 | 330,549 | 280 K to 330.5 K (+18.06 %) |
| Feb 07 2017 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.01 | 17,895 | 179 | 279,982 | 262.1 K to 280 K (+6.83 %) |
| Feb 03 2017 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CLO & CAO | Sell | S | 85.98 | 3,450 | 296,631 | 10,350 | 13.8 K to 10.4 K (-25.00 %) |
| Feb 03 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 85.91 | 1,500 | 128,865 | 110,703 | 112.2 K to 110.7 K (-1.34 %) |
| Feb 03 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 85.08 | 400 | 34,032 | 112,203 | 112.6 K to 112.2 K (-0.36 %) |